
SELUTION SLR Drug-Eluting Balloon
Description: Cordis Announces Groundbreaking Results of SELUTION DeNovo and SELUTION4ISR Randomized Trials that Move Coronary Artery Disease (CAD) Treatment Beyond Stenting at TCT 2025

TauroPace™
Description: TauroPace™ is an antimicrobial solution designed to ensure that CIEDS (Cardiac Implantable Electronic Devices) remain sterile prior to implantation.

TauroLock™-HEP500
Our product range consists of various lock solutions customized to meet the individual needs of each patient. TauroLock™-HEP500, containing 500 IU/ml of heparin, was designed to minimize occlusion rates during dialysis treatment



